ArticleEmerging microbes & infections2023
NSUN2-mediated M
Open access · goldAbstract read
In one paragraph
Article in Emerging microbes & infections, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 42 papers.
0numbers the graph read from it
0cells of the map it votes in
42citing papers in PubMed
7.1field-weighted citation impact, top 2% of its field
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
42 citing papers in PubMed, 46 citations in OpenAlex.
- NSUN2‑mediated epitranscriptomic and ubiquitin modulation of Nipah virus matrix protein reveals a dual-targeting antiviral strategy.Protein & cell · 2026Article
- N6-methyladenosine modification in the context of viral infection: from molecular mechanism to therapeutic potential.Virus research · 2026Review
- Global research trends on the relationship between RNA mBiophysics reports · 2026Article
- m5C RNA methylation is dysregulated by oncogenic herpesviruses via c-Myc signaling to counteract host antiviral factors.Nucleic acids research · 2026Article
- Enhancing plant antiviral responses and productivity through the elimination of mScience advances · 2026Article
- MCell death & disease · 2026Article
- The two-step purification method ViREn identifies a single NSUN6-mediated 5-methylcytosine modification promoting dengue virus RNA genome turnover.Nucleic acids research · 2026Article
- NSUN2-Mediated mInternational journal of general medicine · 2026Review
- NSUN2-mediated m5C modification of SOCS3 mRNA modulates macrophage polarization in bladder cancer.Cell death & disease · 2025Article
- Flaviviridae RdRp exploits NSUN2-driven m5C methylation to establish persistent infection.PLoS pathogens · 2025Article
- The Role of NSUN Family Genes in m5C Methylation and Diseases.Biomedicines · 2025Review
- Epigenomic Transcriptome Regulation of Growth and Development and Stress Response in Cucurbitaceae Plants: The Role of RNA Methylation.Current issues in molecular biology · 2025Review
- Analysis of the Porcine Reproductive and Respiratory Syndrome Virus Nucleocapsid Interactome.Journal of proteome research · 2025Article
- Epitranscriptomic Regulation of Hepatitis B Virus by RNA 5-Methylcytosine: Functions, Mechanisms, and Therapeutic Potential.Viruses · 2025Review
- Cross-lineage 5-methylcytosine methylome profiling reveals methylated divergence among Toxoplasma gondii tachyzoites of the three major clonal lineages.Infectious diseases of poverty · 2025Article
- NSUN2 inhibits NCOA4 expression to alleviate ferroptosis and inflammation in sepsis-induced myocardial injury in a mJournal of cardiothoracic surgery · 2025Article
- Exploring the mFunctional & integrative genomics · 2025Article
- RNA modification gene WDR4 facilitates tumor progression and immunotherapy resistance in breast cancer.Journal of advanced research · 2025Article
- The ELF3-TRIM22-MAVS signaling axis regulates type I interferon and antiviral responses.Journal of virology · 2025Article
- NSUN2-mediated HCV RNA m5C Methylation Facilitates Viral RNA Stability and Replication.Genomics, proteomics & bioinformatics · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
21 authors at 4 institutions in 2 countries.
Hongyun WangState Key Laboratory of Virology, RNA Institute, College of Life Sciences, Wuhan University, Wuhan, People's Republic of China.
Jiangpeng FengState Key Laboratory of Virology, RNA Institute, College of Life Sciences, Wuhan University, Wuhan, People's Republic of China.
Cong ZengState Key Laboratory of Virology, RNA Institute, College of Life Sciences, Wuhan University, Wuhan, People's Republic of China.
Jiejie LiuState Key Laboratory of Virology, RNA Institute, College of Life Sciences, Wuhan University, Wuhan, People's Republic of China.
Zhiying FuState Key Laboratory of Virology, RNA Institute, College of Life Sciences, Wuhan University, Wuhan, People's Republic of China.
Dehe WangState Key Laboratory of Virology, RNA Institute, College of Life Sciences, Wuhan University, Wuhan, People's Republic of China.ORCID 0000-0002-9465-0957
Yafen WangCollege of Chemistry and Molecular Sciences, Wuhan University, Wuhan, People's Republic of China.
Lu ZhangState Key Laboratory of Virology, RNA Institute, College of Life Sciences, Wuhan University, Wuhan, People's Republic of China.
Jiali LiState Key Laboratory of Virology, RNA Institute, College of Life Sciences, Wuhan University, Wuhan, People's Republic of China.
Ao JiangState Key Laboratory of Virology, RNA Institute, College of Life Sciences, Wuhan University, Wuhan, People's Republic of China.
Miao HeSchool of Medicine, Sun Yat-sen University, Guangzhou, People's Republic of China.
Yuanyuan CaoDepartment of Microbiology, School of Basic Medical Sciences, Anhui Medical University, Hefei, People's Republic of China.
Kun YanState Key Laboratory of Virology, RNA Institute, College of Life Sciences, Wuhan University, Wuhan, People's Republic of China.
Hao TangHeart Center of Henan Provincial People's Hospital, Central China Fuwai Hospital of Zhengzhou University, Zhengzhou, People's Republic of China.
Deyin GuoSchool of Medicine, Sun Yat-sen University, Guangzhou, People's Republic of China.
Ke XuState Key Laboratory of Virology, RNA Institute, College of Life Sciences, Wuhan University, Wuhan, People's Republic of China.
Xiang ZhouCollege of Chemistry and Molecular Sciences, Wuhan University, Wuhan, People's Republic of China.
Li ZhouState Key Laboratory of Virology, RNA Institute, College of Life Sciences, Wuhan University, Wuhan, People's Republic of China.
Ke LanState Key Laboratory of Virology, RNA Institute, College of Life Sciences, Wuhan University, Wuhan, People's Republic of China.
Yu ZhouState Key Laboratory of Virology, RNA Institute, College of Life Sciences, Wuhan University, Wuhan, People's Republic of China.
Yu ChenState Key Laboratory of Virology, RNA Institute, College of Life Sciences, Wuhan University, Wuhan, People's Republic of China.ORCID 0000-0003-1300-4652
Wuhan University · CNSun Yat-sen University · CNAnhui Medical University · CNZhengzhou University · CN
Funding
No grant is acknowledged in the PubMed record.
Abstract
5-Methylcytosine (m
Indexed as
COVID-19Interferon Type IVirus DiseasesZika VirusZika Virus InfectionAnimalsImmunity, InnateInterferon-betaInterferon Regulatory Factor-3MethylationMiceMice, KnockoutSARS-CoV-2Interferon-betaInterferon Regulatory Factor-3Interferon Type IIrf3 protein, mouse5-methylcytosineantiviral innate immunityRNA methyltransferaseSARS-CoV-2viral infections
Identifiers
What OpenQuestion holds
Textmetadata
LicenceCC BY-NC
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.